Fake research papers fuelling AI algorithms, turning fiction into fact
HQ Team April 21, 2026: When a Swedish researcher named Almira Osmanovic Thunström invented a disease called “bixonimania” in early 2024, she expected.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team April 21, 2026: When a Swedish researcher named Almira Osmanovic Thunström invented a disease called “bixonimania” in early 2024, she expected.
Healthquill Team and Bhartijay April 21, 2026: In 2011, sociologist Javier Auyero spent six months sitting in a welfare office in Buenos Aires..
Swati Sri A Washington State University (WSU) study has uncovered the biological mechanism behind one of the most frustrating aspects of endometriosis: why.
About 4.9 million children died before their fifth birthday in 2024, including 2.3 million newborns, according to a UN report.
High antibiotic use may have a long-term effect on a person’s gut microbiome, and certain antibiotics can cause changes in the community of.
Six small ribonucleic acid (RNA) molecules in the blood may be able to predict short-term survival with an 86% accuracy, a study finds.
A 13,000-year-old ice cave, located in Romania’s northwestern Apuseni mountains of Transylvania, is housing bacteria that are resistant to about 10 modern antibiotics.
Ravens remember where wolves are most likely to make kills and will return to those kill sites from far away — flying up.
HQ Team March 14, 2026: A specific bacterium that causes severe gum disease can invade the bloodstream, travel to the heart, and directly.
HQ Staff Writer March 13, 2026: Researchers have developed a promising new class of antibiotic, EVG7, an experimental glycopeptide to treat gut infection, Clostridioides difficile (C..
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com